Home Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
Article Open Access

Gut microbiota changes associated with low-carbohydrate diet intervention for obesity

  • Li Li , Xiaoguo Zhao , Rashidin Abdugheni , Feng Yu , Yunyun Zhao , Ba-Fang Ma , Zhifang Yang , Rongrong Li , Yue Li , Yasen Maimaitiyiming EMAIL logo and Mayila Maimaiti EMAIL logo
Published/Copyright: January 27, 2024
Download Article (PDF)
Open Life Sciences
From the journal Open Life Sciences Volume 19 Issue 1

Abstract

Low-carbohydrate diets (LCDs) are frequently recommended for alleviating obesity, and the gut microbiota plays key roles in energy metabolism and weight loss. However, there is limited in-human research on how LCD changes gut microbiota. In this before–after study, 43 participants were assigned to the LCD intervention for 4 weeks. The main objective was to investigate the specific changes that occur in the participants’ microbiome in response to the LCD. Changes in gut microbiota were analyzed using 16s rRNA sequencing. Body composition was measured using InBody 770. Remarkably, 35 participants (79.07%) lost more than 5% of their body weight; levels of BMI, body fat, and total cholesterol were significantly decreased, indicating the effectiveness of the LCD intervention. The richness of microbiota significantly increased after the intervention. By taking the intersection of ANOVA and linear discriminant analysis effect size (LEfSe) analysis results, we identified three phyla, three classes, four orders, five families, and six genera that were differentially enriched between baseline and week-4 time points. Among the three phyla, relative abundances of Firmicutes and Actinobacteriota decreased significantly, while Bacteroidetes increased significantly. At the genus level, Ruminococcus, Agathobacter, Streptococcus, and Bifidobacterium showed a significant reduction in relative abundances, whereas Parabacteroides and Bacteroides increased steadily. Our results demonstrate that LCD can effectively alleviate obesity and modify certain taxa of gut microbiota, providing potential insights for personalized dietary interventions against obesity.

Graphical abstract

Keywords: low-carbohydrate diet; gut microbiota; obesity; weight loss; 16s rRNA sequencing

1 Introduction

Obesity, a global health problem, affects a significant number of people worldwide [1,2]. This complex disorder is characterized by an imbalance between energy intake and expenditure, leading to excessive body fat accumulation [3]. In recognition of World Obesity Day on March 4, 2022, the World Health Organization (WHO) reported staggering statistics: over 1 billion individuals, including 650 million adults, 340 million teenagers, and 39 million children, are classified as obese (BMI ≥ 30 kg/m2) globally [4]. It is more alarming to note that these numbers continue to increase. Obesity not only predisposes individuals to various health issues but also increases the risk of developing several disorders such as asthma, cardiovascular diseases, osteoarthritis, sleep disorders, type 2 diabetes mellitus, mental health issues, nonalcoholic fatty liver disease, and certain types of cancer, among others [5,6,7,8,9,10]. These obesity-related diseases are major contributors to premature or preventable deaths [11]. Consequently, extensive research has focused on investigating the factors contributing to obesity as well as developing effective intervention strategies to prevent its occurrence.

Obesity is believed to be influenced by a combination of factors, including genetic susceptibility, physiological and biological pathways related to metabolism and body weight regulation, physical activity and exercise choices, as well as dietary habits and environmental factors [1,2,3]. In response to this understanding, various strategies have been developed to address obesity. These include pharmacotherapy [12], surgical treatment [13], exercise therapy [9], and dietary interventions among others [14], all of which have pros and cons, respectively. Pharmacotherapy and surgical treatment are options for obesity management but come with inherent costs and potential risks [2,15]. In contrast, exercise therapy is a relatively economical option, but its effectiveness relies on long-term and consistent adherence, which can be challenging or even impossible for individuals who are overweight or obese [16]. In comparison, dietary interventions are currently considered a popular, conservative, and convenient strategy for treating and managing obesity. Such interventions are highly safe, cost-effective, and offer a promising approach when compared to other alternative strategies [14,17].

Among the various dietary patterns that have been studied for their effectiveness in weight loss and managing obesity-related comorbidities, the low-carbohydrate diet (LCD) stands out as a widely studied approach [18,19,20]. A study found that LCD intervention is superior to exercise in improving obesity [21]. Their results showed that after a 3-week intervention, the LCD group experienced greater weight loss (−3.56 ± 0.37 kg) compared to the exercise group (−1.24 ± 0.39 kg), as well as larger reductions in fat mass, waist circumference, and various glycemic parameters. While debates persist regarding the comparative effectiveness of LCDs versus low-fat diets (LFDs) or energy-restricted weight loss diets, there is a consensus that LCDs have a positive impact on reducing body mass index (BMI), body fat, waist circumference, blood pressure, serum lipid levels, insulin levels, etc. [22,23]. Inconsistencies observed in randomized controlled trials may be attributed to variations in dietary composition [24]. However, the individual variability in response to LCD within a trial highlights the need to consider other factors that influence weight loss.

Accumulating evidence suggests that the gut microbiota (GMB) plays a crucial role in obesity by influencing energy intake and nutrient absorption in the host [25]. The GMB contributes to obesity through various mechanisms. Dietary patterns have been found to influence the composition and diversity of the GMB [26]. Interestingly, the GMB also influences dietary intake through gut–microbiome–brain interactions, indicating a bidirectional relationship between diet and the GMB [27]. Animal studies have demonstrated that fecal transplantation from obese mice to germ-free mice results in weight gain and the development of obesity-related metabolic phenotypes, which can be alleviated by cohabitation with mice harboring the microbiota of lean co-twins [28]. When the germ-free mice were colonized with the conventional GMB, they notably gained weight and exhibited over 50% increased levels of body fat [29]. GMB can increase energy extraction by breaking down complex carbohydrates and producing fatty acids [30]. Gut bacteria also impact metabolism, influencing the absorption and storage of nutrients [31]. For instance, short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, can promote fat storage, while trimethylamine and trimethylamine N-oxide from certain gut bacteria have been associated with increased obesity and metabolic dysfunction. Additionally, they regulate appetite and food cravings by affecting hormone production [32]. Imbalances in gut bacteria can promote inflammation and insulin resistance, further contributing to weight gain [33]. Taken together, these findings suggest that the GMB may serve as a mediator in the effects of LCD interventions on obesity [25]. However, there is limited research on the effects of LCDs on anthropometric profiles, body composition, and GMB in humans. Further exploration is needed to: (1) evaluate the impact of LCD on individuals’ health indicators, and (2) understand the influence of LCD on the composition and structure of the host’s gut microbiome. Thus, the main objective of this study was to investigate the specific changes that occur in the participants’ microbiome in response to the LCD.

In this study, we examined the effects of a 4-week LCD intervention on anthropometric profiles, body composition, and GMB of participants. The results demonstrated that the LCD intervention effectively reduced body weight (−6.14 kg [95% CI, −5.37 to −6.92 kg]; p < 0.001), BMI (−2.26 kg/m2 [95% CI, −1.96 to −2.56 kg/m2]; p < 0.01), body fat, (−4.73 kg [95% CI, −4.10 to −5.35 kg]; p < 0.001), visceral fat area (−21.25 cm2 [95% CI, −17.59 to −24.91 cm2]; p < 0.001), and serum total cholesterol levels. These findings indicate that the LCD intervention strategy was successful in treating obesity. Notably, we observed changes in the abundance of microbial phyla following the intervention. Specifically, there was an enrichment of Bacteroidetes (including genera Parabacteroides and Bacteroides), which have been associated with lower obesity risk. Conversely, there was a reduction in the abundance of Firmicutes (including genera Ruminococcus, Agathobacter, Streptococcus) and Actinobacteriota (now Actinomycetota) (including the genus Bifidobacterium), which have been linked to higher obesity risk. These findings suggest that our LCD intervention effectively modulated the composition of the participants’ GMB, providing a foundation for long-term digestive system health. In summary, this study demonstrated that LCD can effectively alleviate obesity and induce changes in specific gut microbial taxa. These observations may contribute to a better understanding of the mechanisms underlying LCD-mediated weight loss and offer potential insights for personalized dietary interventions against obesity.

2 Materials and methods

2.1 Study participants

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University on June 22, 2020 (no. K202006-18). The study was implemented from July 2020 to June 2021. Overweight/obese but otherwise healthy participants, male and female, were voluntarily enrolled in the weight loss program (low-carbohydrate dietary guidance) of the Department of Clinical Nutrition, First Affiliated Hospital of Xinjiang Medical University. Written informed consents were taken from every participant prior to the study. All the participants have BMIs over 25 kg/m2 (33.43 kg/m2 on average). The exclusion criteria include consumption of alcohol or tobacco, participating in specific eating plans or excessive training programs at recruitment, undertaking any medication (prescribed drugs or antibiotics) treatment, and having an unstable weight (variation > 5%) in the past 6 months. As a result, a total of 61 participants were included in the study.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University on 22 June 2020 (no. K202006-18).

2.2 Study design, body composition, and metabolic parameters

This before–after study aimed to assess the changes in GMB among participants before and after a 4-week dietary intervention. All participants were enrolled in a single-arm study and assigned to a low-calorie diet intervention. Prior to the intervention, participants underwent 2 weeks of normal diet as a baseline. Subsequently, they switched to the LCD for 4 weeks. Trained dietitians maintained regular communication with participants through daily telephone calls or via a social app (WeChat) to ensure adherence to the LCD guidelines. During the study, fecal samples, body composition measurements, and blood tests were conducted at baseline and the end of the 4-week intervention period. Fecal samples were stored at −80°C prior to microbiome sequencing. Body composition measurements were performed using the InBody 770 at the outpatient clinic of the First Affiliated Hospital of Xinjiang Medical University. Out of the initial 61 participants, 43 returned for body composition measurements, blood tests, and fecal sampling. Therefore, all subsequent analyses related to body composition and GMB sequencing were conducted on these 43 participants. Detailed demographic data of the participants can be found in Table 1.

Table 1

Demographic characteristics of study participants and changes in anthropometric profiles after LCD intervention

Parameters Baseline (n = 43) Week 4 (n = 43) p value
Female/male 28/15 28/15
Age, years 31.51 (±10.50) 31.51 (±10.50)
Weight 92.01 (±18.83) 85.87 (±17.88) 0.000
BMI 33.43 (±5.20） 31.17 (±4.83) 0.000
Ethnicity 36 36
Han 4 4
Uyghur 2 2
Hui 1 1
Kazakh 1 1
Waistline (cm) 107.17 (±13.10) 99.20 (±13.07) 0.000
Hip circumference (cm) 113.88 (±9.63) 108.48 (±9.85) 0.000
Waist-to-hip fat ratio 0.99 (±1.52) 0.96 (±0.08) 0.005
Body fat (kg) 38.70 (±11.17) 33.97 (±10.75) 0.000
Skeletal muscle (kg) 29.67 (±6.92) 33.97 (±10.75) 0.237
Defatted body weight (kg) 53.32 (±11.45) 51.89 (±11.37) 0.203
Protein (kg) 10.49 (±2.28) 10.23 (±2.27) 0.246
Body moisture content (kg) 39.13 (±8.35) 38.05 (±8.31) 0.188
Intracellular fluid (kg) 24.29 (±5.31) 23.67 (±5.26) 0.232
Extracellular fluid (kg) 14.85 (±3.06) 14.38 (±3.06) 0.132
Inorganic salt (kg) 3.68 (±0.82) 3.61 (±0.80) 0.312
Body fat percentage (%) 41.80 (±6.73) 39.23 (±7.64) 0.004
Basal metabolic rate 1521.40 (±247.20) 1459.32 (±312.46) 0.052
Visceral fat area (cm2) 175.89 (±49.11) 154.64 (±52.13) 0.000
Total cholesterol (mg/dL) 1.98 (±1.04) 1.05 (±0.31) 0.000
Triglyceride (mg/dL) 5.03 (±1.07) 4.76 (±1.04) 0.153
HDL-C (mg/dL) 1.13 (±0.25) 1.08 (±0.27) 0.359
LDL-C (mg/dL) 3.40 (±0.82) 3.36 (±0.89) 0.791

2.3 Dietary intervention (LCD)

Participants were asked to take LCD (carbohydrate 25%, protein 45%, fat 30%), with drinking water of at least 1.8 L/day. Daily caloric intake (kcal) = ideal body weight (kg) × (20–25) × 75%. Ideal body weight (kg) = height (cm) −105. The dietary choices were mainly composed of low-glycemic and high-protein foods. Taboo foods included rice flour and other high-starch foods, fruits, cakes and other sweets, wines, and beverages. Vegetable oil was chosen as the main cooking oil. Participants adopted commercialized meal replacement bars and dietary fiber powders to ensure the LCD structure. Specific dietary recommendations: for breakfast, one egg, one bag of meal replacement milkshake, and one bag of dietary fiber powder; for lunch, a meal replacement bar, 200 g of raw meat (steamed or boiled fish and shrimp were priorities), and 150 g of raw non-starch vegetables; for dinner, a meal replacement bar, 150–200 g of raw meat (steamed or boiled fish and shrimp were priorities), and 150 g of raw non-starch vegetables. Each bag of meal replacement milkshake contained 7.3 g carbohydrate, 14.4 g protein, and 1.8 g fat, weighing 28 g and providing 107.5 kcal of energy. Each meal replacement bar contained 28.6 g carbohydrate, 31.2 g protein, and 14.3 g fat, weighing 56 g and providing 189.71 kcal of energy. Each bag of dietary fiber powder weighed 8 g, providing 12.42 kcal of energy. The body weight and urine ketone of participants were closely monitored. The intervention period lasted for 4 weeks (28 days).

2.4 16S rRNA gene-based microbiome sequencing

The 16S rRNA gene (rDNA) sequencing was conducted by Biomarker Biotechnology Co., Ltd (Beijing, China). Following extraction of the total DNA from samples, specific primers with Barcode (27 F, 5′-AGRGTTTG ATYNTGGCTCAG-3′; 1492 R, 5′-TASGGHTACCTTGTTASGACTT-3′) were used to amplify the full-length sequence (V1–V9) of the 16S rRNA gene [34]. Then, the products were purified, homogenized, and quantified to form a sequencing library. After library quality inspection, the eligible library is sequenced with the PacBio Platform. The optimized circular consensus sequences (CCS) were obtained by filtering with the threshold of minPasses ≥5 and minPredictedAccuracy ≥ 0.9 [35]. After pre-processing the sequencing data, bioinformatics analysis is performed.

2.5 Bioinformatics analysis

In this study, all the bioinformatics analyses were performed using BMK Cloud (Biomarker Technologies Co., Ltd; www.biocloud.net). Sequences with >97% similarity were clustered into the same operational taxonomic unit (out) by USEARCH (v10.0) [36]. OTUs with an abundance of <0.005% were filtered. Taxonomic annotation of the OTUs was carried out based on the Naive Bayes classifier in QIIME2 (Version 1.8.0) using the SILVA database (release132) with a confidence threshold of 70% [37]. The alpha (α) and beta (β) diversities were calculated and visualized using the QIIME pipeline and R software. PCoA and PERMANOVA/ANOSIM analyses were performed for the β diversity estimation. The significant taxonomic differences were assessed by one-way ANOVA and the linear discriminant analysis (LDA) effect size (LEfSe). The logarithmic LDA score threshold was 3.5 for discriminative features.

2.6 Statistical analysis

Statistical analysis for comparison of the body composition and metabolic parameters was conducted using SPSS software (SPSS Statistics, v. 23). The results were expressed as mean ± SD (or SE), and differences were considered statistically significant at a p value < 0.05 (*p < 0.05; **p < 0.01; ***p < 0.001). Differences in demographic as well as anthropometric profiles, body composition, body fat distribution, and clinical and biochemical measurements were evaluated using paired t-test. One-way ANOVA analysis was performed at multiple taxonomic levels (phylum, class, order, family, genus, and species) to identify differentially enriched taxa between the two groups. Additionally, Benjamin and Hochberg’s false discovery rate method was used to correct and adjust p-values [38]. LEfSe with the default α value of 0.05 was carried out using BMKCloud (www.biocloud.net) to screen taxa that serve most possibly as biomarkers between the two time points.

3 Results

3.1 Effects of LCD on the body weight, body composition, and anthropometric profiles

After intervention with the LCD for 4 weeks, a significant reduction in the body weight (−6.14 kg [95% CI, −5.37 to −6.92 kg]; p < 0.001) and BMI (−2.26 kg/m2 [95% CI, −1.96 to −2.56 kg/m2]; p < 0.01) of the participants was noted (Figure 1a and b), which mainly resulted from a loss of body fat (−4.73 kg [95% CI, −4.10 to −5.35 kg]; p < 0.001) (Figure 1c and d). Notably, 34 of 43 (79.07%) participants gained a weight loss of at least 5% body weight, indicating the effectiveness of the intervention. The average visceral fat area of study participants was 175.89 cm2 at the baseline, and it decreased to 154.64 cm2 after 4 weeks of intervention (−21.25 cm2 [95% CI, −17.59 to −24.91 cm2]; p < 0.001) (Figure 1e). Other anthropometric profiles and body composition data including basal metabolic rate, waistline, hip circumference, and waist-to-hip fat ratio (Figure 1f–i) were also significantly decreased, along with a significant reduction in total cholesterol levels (Table 1). Collectively, the results of this study indicate that a 4-week LCD intervention leads to significant and meaningful anti-obesity effects. These findings provide strong evidence for the efficacy of LCD in promoting weight loss and combating obesity.

Figure 1 Scatter diagrams showing changes in body weight (a), BMI (b), body fat (c), body fat percentage (d), visceral fat area (e), basal metabolic rate (f), waisline (g), Hip circumference (h) and Waist-to-hip fat ratio (i) of participants after 4 weeks of LCD intervention.
Figure 1

Scatter diagrams showing changes in body weight (a), BMI (b), body fat (c), body fat percentage (d), visceral fat area (e), basal metabolic rate (f), waisline (g), Hip circumference (h) and Waist-to-hip fat ratio (i) of participants after 4 weeks of LCD intervention.

3.2 General profile of GMB composition

A total of 86 fecal samples were sequenced and subjected to Barcode identification, which produced 580,075 CCS in total. Specifically, each sample produced at least 4,027 CCS, with an average of 6,745 CCS. The number of OTUs in each sample is shown in supplementary Figure S1. A total of 487 and 510 OTUs were found at the baseline and week 4, respectively, with a total of 551 OTUs in all samples (Figure 2a). Although most OTUs (464) overlapped between the two time points, there were 41 baseline-specific and 64 week-4-specific OTUs (Figure 2b). Taxonomic analysis revealed that these microbiotas belong to 12 phyla (Figure 2c). The relative abundance of the top 20 microbiome at family and genus levels are displayed in Figure 2d and e. Consistent with previous findings [27], our results showed that Firmicutes (now Bacillota) and Bacteroidota (previously known as Bacteroidetes) are the top two abundant bacterial phyla in the fecal samples and the Faecalibacterium is the most abundant genus (Figure 2c and e).

Figure 2 Overview of changes in multiple taxonomic levels by LCD intervention. (a) Bar chart showing OTU (feature) numbers at baseline and week 4. (b) Van diagram of OTUs at baseline and week 4. (c–e) Overview of microbiota levels at phylum, family, and genus levels at baseline and week 4.
Figure 2

Overview of changes in multiple taxonomic levels by LCD intervention. (a) Bar chart showing OTU (feature) numbers at baseline and week 4. (b) Van diagram of OTUs at baseline and week 4. (c–e) Overview of microbiota levels at phylum, family, and genus levels at baseline and week 4.

3.3 α and β diversity

α Diversity is a measure to evaluate the microbiota richness and diversity (or complexity) within samples. The rarefaction curve of each sample at baseline as well as week 4 were steeply increased and gradually reached a plateau, suggesting that the amount of sequencing data is sufficient to reflect the species diversity in each sample (Figure 3a and b). The abundance-based coverage estimator (ACE) and Chao 1 indices at week 4 were significantly increased as compared to that of the baseline, suggesting an increased richness of microbiota within each sample after 4 weeks of LCD intervention (Figure 3c and d). Intriguingly, while the Shanon and Simpson indices displayed a slight upward trend in the week-4 group, the differences compared to the baseline were not statistically significant (Figure S2a and b). This suggests that the diversity of the microbiota is not significantly increased following a 4-week intervention. β Diversity aims to evaluate the microbiota complexity between samples. Here, the PCoA analysis of Weighted Unifrac distance and Bray–Curtis dissimilarity revealed certain differences between the baseline and week-4 time points (Figure 3e and f). Further analysis of PERMANOVA/Anosim indicated a subtle inter-group but not intra-group differences (Supplementary Figure S2c–f), suggesting that the LCD intervention resulted in certain changes in GMB.

Figure 3 Changes in α and β diversity after the LCD intervention. (a and b) Rarefaction curves of all samples (86) as well as baseline and week 4 groups. (c and d) Box plots showing alterations in ACE and Chao1 indices. (e and f) Principal coordinates analysis (PCoA) of Bray–Curtis dissimilarity data and weighted unifrac.
Figure 3

Changes in α and β diversity after the LCD intervention. (a and b) Rarefaction curves of all samples (86) as well as baseline and week 4 groups. (c and d) Box plots showing alterations in ACE and Chao1 indices. (e and f) Principal coordinates analysis (PCoA) of Bray–Curtis dissimilarity data and weighted unifrac.

3.4 Alterations in the microbiota composition after LCD intervention

After a 4-week LCD intervention, significant changes in the composition of the GMB were observed through ANOVA analysis. In both baseline and week-4 time points, the top three phyla (Firmicutes, Bacteroidota, and Proteobacteria) constituted more than 97% of the total GMB (Table 2). Notably, among the top three phyla, the relative abundance of Firmicutes and Bacteroidota but not Proteobacteria (now Pseudomonadota) changed significantly after the intervention. Specifically, the relative abundance of Firmicutes was significantly reduced from 73.61% at baseline to 60.26% at week 4. In contrast, the relative abundance of Bacteroidota was significantly increased from 16.13% at baseline to 30.73% at week 4. Consistent with previous reports, the ratio of Firmicutes to Bacteroidota was significantly decreased following the intervention (Figure S3). Other phyla with statistically significant alteration in abundance by the intervention include Actinobacteriota, Patescibacteria, and Desulfobacterota. Among these, the relative abundances of Actinobacteriota and Patescibacteria were significantly decreased, and the relative abundance of Desulfobacterota was significantly increased (Table 2).

Table 2

Alterations in mean relative abundance of bacterial phyla after the intervention

Phylum Mean relative abundance p-value
Baseline Week 4 p Adjusted p
Firmicutes 73.6078 60.2637 0.000295 0.001473
Bacteroidota 16.1290 30.7295 0.000013 0.000160
Proteobacteria 8.2690 6.7383 0.575194 0.690233
Actinobacteriota 0.9746 0.1415 0.000368 0.001473
Fusobacteriota 0.6284 0.8277 0.796949 0.796949
Verrucomicrobiota 0.2746 1.1088 0.300819 0.501151
Patescibacteria 0.0609 0.0151 0.036505 0.087612
Desulfobacterota 0.0524 0.1218 0.031814 0.087612
Campylobacterota 0.0015 0.0019 0.700477 0.764156
Fibrobacterota 0.0013 0.0087 0.379032 0.505376
Elusimicrobiota 0.0005 0.0166 0.334101 0.501151
Cyanobacteria 0.0000 0.0263 0.129971 0.259941

The bold values emphasize statistical significance.

We next summarized the relative abundance of all taxa with statistically significant differences between groups at the phylum, class, order, family, and genus levels (Table 3). As far as the phyla Firmicutes is concerned, the reduction in relative abundance was mainly due to the decrease in class Clostridia, orders Lachnospirales and Lactobacillales, families Lachnospiraceae and Streptococcaceae; at the genus level, most taxa with higher relative abundance (Subdoligranulum, Ruminococcus, Agathobacter, [Eubacterium] _hallii_group, and Streptococcus) at baseline were significantly decreased by 4 weeks of intervention. Notably, among the Firmicutes phyla, where the relative abundance was significantly decreased by 4 weeks of intervention, several low-abundance genera (Flavonifractor, Oscillibacter, UCG_003, Anaerotruncus, Tuzzerella, and Fusicatenibacter) were significantly increased by the intervention. As for the phyla Bacteroidota, the increment in relative abundance was due to the increase in class Bacteroidia, order Bacteroidales, families Bacteroidaceae, Tannerellaceae, and Marinifilaceae; at the genus level, the relative abundance of Paraprevotella, Bacteroides, Parabacteroides, and Odoribacter were all consistantly increased. Likewise, reduction of the relative abundance in phyla Actinobacteriota was mainly owing to a decrease in class Actinobacteria, orders Bifidobacteriales, Micrococcales and Actinomycetales, families Bifidobacteriaceae, Micrococcaceae, and Actinomycetaceae; at the genus level, relative abundance of Actinomyces, Bifidobacterium, and Rothia were all reduced. In the case of Patescibacteria phyla, the reduction in its relative abundance was due to the decrease in the relative abundance of class Saccharimonadia, order Saccharimonadales, family Saccharimonadaceae, and genus TM7x. The least abundant phylum with significant differences among the baseline and week-4 groups is Desulfobacterota, where the relative abundance is significantly increased due to the enrichment in class Desulfovibrionia, order Desulfovibrionales, and family Desulfovibrionaceae.

Table 3

Significantly (p < 0.05) altered taxa from phylum to genus levels after 4 weeks of HPLC intervention

Taxon Annotation Mean relative abundance Change p-value
Baseline Week 4 p Adjusted p
Firmicutes Phylum 73.6078 60.2637 ↓ 0.000295 0.001473
Clostridia Class 57.5296 47.5586 ↓ 0.007759 0.041380
Subdoligranulum Genus 4.7349 2.5578 ↓ 0.037976 0.474618
Ruminococcus Genus 2.3861 0.5015 ↓ 0.003707 0.168756
Flavonifractor Genus 0.0357 0.1969 ↑ 0.007047 0.192020
Oscillibacter Genus 0.0332 0.1147 ↑ 0.036549 0.474618
UCG_003 Genus 0.0185 0.0895 ↑ 0.004645 0.168756
[Eubacterium]_nodatum_group Genus 0.0083 0.0009 ↓ 0.006562 0.192020
Anaerotruncus Genus 0.0010 0.0092 ↑ 0.039813 0.474618
Lachnospirales Order 20.5601 14.5661 ↓ 0.015695 0.156947
Lachnospiraceae Family 20.5578 14.5636 ↓ 0.015699 0.349297
Agathobacter Genus 5.8101 0.7451 ↓ 0.004439 0.168756
[Eubacterium]_hallii_group Genus 0.1005 0.0569 ↓ 0.037492 0.474618
Tuzzerella Genus 0.0153 0.0488 ↑ 0.040970 0.474618
Lactobacillales Order 2.5214 0.4689 ↓ 0.040285 0.201426
Streptococcaceae Family 1.3174 0.3774 ↓ 0.034315 0.374262
Streptococcus Genus 1.3163 0.3747 ↓ 0.033824 0.474618
Fusicatenibacter Genus 0.2219 0.4248 ↑ 0.018549 0.449301
Bacteroidota Phylum 16.1290 30.7295 ↑ 0.000013 0.000160
Bacteroidia Class 16.1290 30.7295 ↑ 0.000013 0.000213
Bacteroidales Order 16.0795 30.7247 ↑ 0.000013 0.000520
Paraprevotella Genus 0.1123 0.3300 ↑ 0.043543 0.474618
Bacteroidaceae Family 10.1138 15.4874 ↑ 0.042052 0.374262
Bacteroides Genus 10.1138 15.4874 ↑ 0.042052 0.474618
Tannerellaceae Family 2.2115 9.0084 ↑ 0.000363 0.026717
Parabacteroides Genus 2.2115 9.0084 ↑ 0.000363 0.065442
Marinifilaceae Family 0.1126 0.2400 ↑ 0.020884 0.371738
Odoribacter Genus 0.0750 0.1695 ↑ 0.023405 0.474618
Actinobacteriota Phylum 0.9746 0.1415 ↓ 0.000368 0.001473
Actinobacteria Class 0.9103 0.1103 ↓ 0.000498 0.003984
Actinomyces Genus 0.0137 0.0009 ↓ 0.000901 0.065442
Bifidobacteriales Order 0.8521 0.1002 ↓ 0.000609 0.012008
Bifidobacteriaceae Family 0.8521 0.1002 ↓ 0.000609 0.026717
Bifidobacterium Genus 0.8443 0.0960 ↓ 0.000665 0.065442
Micrococcales Order 0.0445 0.0092 ↓ 0.028809 0.201426
Micrococcaceae Family 0.0445 0.0092 ↓ 0.028809 0.374262
Rothia Genus 0.0445 0.0092 ↓ 0.028809 0.474618
Actinomycetales Order 0.0137 0.0009 ↓ 0.000901 0.012008
Actinomycetaceae Family 0.0137 0.0009 ↓ 0.000901 0.026717
Patescibacteria Phylum 0.0609 0.0151 ↓ 0.036505 0.087612
Saccharimonadia Class 0.0609 0.0151 ↓ 0.036505 0.116816
Saccharimonadales Order 0.0609 0.0151 ↓ 0.036505 0.201426
Saccharimonadaceae Family 0.0566 0.0124 ↓ 0.041233 0.374262
TM7x Genus 0.0471 0.0067 ↓ 0.037719 0.474618
Desulfobacterota Phylum 0.0524 0.1218 ↑ 0.031814 0.087612
Desulfovibrionia Class 0.0524 0.1218 ↑ 0.031814 0.116816
Desulfovibrionales Order 0.0524 0.1218 ↑ 0.031814 0.201426
w Family 0.0524 0.1218 ↑ 0.031814 0.374262

“↓” denotes reduction in relative abundance and “↑” indicates upregulation in relative abundance.

3.5 LEfSe analysis of GMB taxonomic biomarkers

Based on the above results, we further performed LEfSe to identify core taxa contributing to the differences between the baseline and week-4 time points. We set the LDA threshold at 3.5. This analysis showed three phyla, three classes, five orders, seven families, and ten genera to be differentially enriched between the baseline and week-4 groups (Figure 4a and b). The relative abundance of the three phyla in every sample is shown in Figure 4c–e, displaying a significant reduction in Firmicutes and Actinobacteriota, along with a significant increase in the relative abundance of Bacteroidota at week 4 compared to the baseline.

Figure 4 LEfSe analysis of gut microbiota taxonomic biomarkers. (a and b) Cladogram and LDA bar column plotted from LEfSe analysis. The logarithmic LDA score threshold was 3.5 for discriminative features. (c–e) Bar graphs showing changes in relative abundance of three differentially enriched phylum. The solid and dashed lines show the mean and median relative abundance values of each taxon. (f) Overlapped genus between ANOVA and LEfSe analyses and their changes after LCD intervention. “↓” denotes reduction in relative abundance and “↑” indicates upregulation in relative abundance.
Figure 4

LEfSe analysis of gut microbiota taxonomic biomarkers. (a and b) Cladogram and LDA bar column plotted from LEfSe analysis. The logarithmic LDA score threshold was 3.5 for discriminative features. (c–e) Bar graphs showing changes in relative abundance of three differentially enriched phylum. The solid and dashed lines show the mean and median relative abundance values of each taxon. (f) Overlapped genus between ANOVA and LEfSe analyses and their changes after LCD intervention. “↓” denotes reduction in relative abundance and “↑” indicates upregulation in relative abundance.

To ensure a comprehensive analysis, we considered the intersection of the results obtained from both ANOVA and LEfSe analysis. As ANOVA and LEfSe employ different algorithms to identify differentially enriched taxa between the baseline and week 4, combining their findings provided a more robust and reliable assessment. This analysis identified three phyla (Bacteroidota, Firmicutes, and Actinobacteriota), three classes (Bacteroidia, Clostridia, and Actinobacteria), four orders (Bacteroidales, Lachnospirales, Lactobacillales, and Bifidobacterials), five families (Tannerellaceae, Bacteroidaceae, Lachnospiraceae, Streptococcaceae, and Bifidobacteriaceae) and six genera (Ruminococcus, Agathobacter, Streptococcus, Parabacteroides, Bacteroides, and Bifidobacterium) (Table 4; Figure 4f). Relative abundance of the six genera in every sample is shown in Figure S4, which displayed a robust reduction in levels of Ruminococcus, Agathobacter, Streptococcus, and Bifidobacterium, and a steady increase in levels of Parabacteroides along with Bacteroides. Taken together, the abovementioned taxa could be used as potential biomarkers behind the effectiveness of short-term LCD intervention.

Table 4

Summary of overlapped taxa from ANOVA and LEfSe analyses

Phyla Class Order Family Genus
Firmicutes↓ Clostridia↓ Ruminococcus↓
Lachnospirales↓ Lachnospiraceae↓ Agathobacter↓
Lactobacillales↓ Streptococcaceae↓ Streptococcus↓
Bacteroidota↑ Bacteroidia↑ Bacteroidales↑ Tannerellaceae↑ Parabacteroides↑
Bacteroidaceae↑ Bacteroides↑
Actinobacteriota↓ Actinobacteria↓ Bifidobacteriales↓ Bifidobacteriaceae↓ Bifidobacterium↓

“↓” denotes reduction in relative abundance and “↑” indicates upregulation in relative abundance.

4 Discussion

GMB is a highly complex community of microorganisms that reside in the gastrointestinal tract and play a crucial role in digestion [27]. Growing evidence indicates that the composition, functions, balance, and interactions of the GMB with the host have a significant impact on human health [25,39]. Human GMB primarily consists of four major phyla: Bacteroides, Firmicutes, Proteobacteria, and Actinobacteria, which collectively account for over 98% of the microbiome [25]. Previous studies have estimated that the human GMB weighs approximately 1–2 kg and is comprised of over 1,000 bacterial species, harboring more than 9 million genes [40,41]. Remarkably, the number of bacterial cells in the gut surpasses that of human cells in the body by a factor of 10 [42]. These findings collectively emphasize the critical role of the GMB in maintaining human health.

In this before–after study, a 4-week intervention with an LCD diet resulted in significant reductions in body weight, BMI, body fat, and visceral fat area, accompanied by a decrease in total cholesterol levels. These findings underscore the effectiveness of the intervention. Moreover, the analysis of 16S rRNA gene sequencing revealed a substantial increase in the diversity of bacterial taxa in each sample following the intervention. Through the integration of ANOVA and LEfSe analyses, we identified several microbiota taxa that responded to the LCD intervention, including three phyla, three classes, four orders, five families, and six genera. Among the three phyla, relative abundances of Firmicutes and Actinobacteriota were decreased significantly and that of Bacteroidetes was increased significantly. At the genus level, we found a significant reduction in relative abundances of Ruminococcus, Agathobacter, Streptococcus, and Bifidobacterium, along with a steady increase in relative abundance of Parabacteroides and Bacteroides. In the following sections, we will discuss the associations of these taxa with obesity and diet.

4.1 Firmicutes to Bacteroidetes ratio, diet, and weight loss

Extensive research activities have been dedicated to identifying the bacterial taxa associated with the onset and control of obesity [43]. It has been demonstrated that the GMB of obese humans or animals exhibits a characteristic higher Firmicutes to Bacteroidetes (F/B) ratio than normal-weight counterparts, suggesting this ratio as a biomarker of obesity [44,45]. This may be explained by the fact that a 20% increase in the relative abundance of Firmicutes and a corresponding decrease in Bacteroidetes are associated with an increased energy harvest of around 150 kcal [46]. Additionally, research suggests that Firmicutes may promote more efficient energy extraction from food [47]. The byproducts of this process, short-chain fatty acids, can contribute to fat storage and weight gain. When obese people lose weight, the F/B ratio was suggested to decrease [44]. In line with this notion, a decreased abundance of Firmicutes over Bacteroidetes and Bifidobacteria is suggested to be beneficial in preventing and treating obesity [48]. In our study, consistent with previous findings, a high F/B ratio was observed among the study participants at the beginning. Likewise, following a 4-week intervention with an LCD diet, a significant decrease in the F/B ratio was observed (p < 0.001) (Figure S3). It is important to note that some studies have failed to establish this relationship [49,50]. Potential factors contributing to these conflicting results include variations in geographical location, weather conditions, regional dietary preferences, duration and composition of interventions, and differences in sample collection and processing methods among other factors. These discrepancies warrant further investigation [51].

4.2 Ruminococcus, Agathobacter, Streptococcus, diet, and weight loss

The Firmicutes phylum is considered a significant bacterial group associated with obesity, as mentioned earlier. Within the Firmicutes phylum, there are over 200 different genera of Gram-positive organisms, primarily responsible for butyrate production in the colon [52]. Studies have shown that germ-free mice, devoid of GMB, have lower body fat compared to mice with a normal GMB, even when subjected to a high-calorie diet [29]. Moreover, the abundance of Firmicutes is positively correlated with obesity levels in these mice. Although the exact mechanisms through which Firmicutes contribute to obesity are not yet fully understood, it is hypothesized that they play a role in increasing energy extraction from the diet [52]. Consequently, it is crucial to further investigate the specific changes in members of this phylum following a weight-loss diet.

In this study, we identified three genera, including Ruminococcus, Agathobacter, and Streptococcus, all of which belong to the order Clostridia (Table 4), to be significantly decreased following short-term LCD intervention. Ruminococcus is reportedly associated with increased absorption of sugars via the breakdown of cellulose (with the formation of methane), which may also contribute to weight gain through sugary foods [53]. Supporting the role of Ruminococcus in obesity, another study also reported an increased abundance of this bacterial taxa in obese mice fed with a high-fat diet [54]. Like most taxa in the Firmicutes phylum, Agathobacter is also a butyrate-producing bacterial genus, the increased abundance of which contributes to obesity. A study reported the enrichment of Agathobacter in the non-alcoholic fatty liver disease group in comparison with the healthy controls [55], suggesting the involvement of this genus in adiposity. In line with our findings, another study also reported a significant reduction in the relative abundance of Agathobacter following caloric restriction of obese women [56]. The Streptococcus genus might play important roles in inflammation and comorbid pneumonia among obese individuals. A previous report indicated that adults with grade-3 morbid obesity (BMI ≥ 40 kg/m2) had a 15-fold higher relative risk of invasive group A Streptococcus infection compared to those of normal weight [57]. Hence, reducing the levels of Streptococcus through LCD intervention in our study may be advantageous in reducing inflammation. Further investigation is warranted to explore the roles of the aforementioned three genera in dietary calorie intake.

4.3 Parabacteroides, Bacteroides, diet, and weight loss

The Bacteroidetes phylum, typically abundant in lean individuals, exhibits decreased relative abundance in the context of obesity. Several studies have reported an increased level of Bacteroidetes in obese individuals following weight-loss interventions [44,45]. The Bacteroidetes phylum encompasses approximately 20 genera of Gram-negative bacteria, which predominantly produce acetate and propionate in the colon [52]. They are associated with lower energy extraction from the diet compared to Firmicutes [46]. The higher abundance of Bacteroidetes observed in vegetarians and vegans further supports this notion [58]. While most studies focus on changes in the overall abundance of the Bacteroidetes phylum after dietary interventions, specific attention to changes in the levels of genera within this phylum has been limited. Our study revealed a robust increase in the relative abundances of Parabacteroides and Bacteroides. In line with our findings, Parabacteroides distasonis has been demonstrated to alleviate obesity and metabolic dysfunctions through the production of succinate and secondary bile acids [59]. Parabacteroides goldsteinii was shown to exert anti-obesity effects in mice [60]. Additionally, an increased abundance of Parabacteroides merdae has been found to protect against obesity-associated atherosclerosis by enhancing branched-chain amino acid catabolism [61]. Furthermore, the gut commensal Bacteroides acidifaciens reportedly prevents obesity and improves insulin sensitivity in mice [62], while Bacteroides have been shown to promote branched-chain amino acid catabolism in brown fat and inhibit obesity in mice [63]. Collectively, these studies support the beneficial role of Parabacteroides and Bacteroides in improving obesity following dietary interventions in our study.

4.4 Bifidobacterium, diet, and weight loss

The Actinobacteria phylum, although representing only a small percentage, is one of the four major phyla of the GMB. Within this phylum, Bifidobacterium has been frequently implicated in obesity. However, the role of Bifidobacterium in obesity is somewhat contradictory [64]. On the one hand, a notable increase in the number of Bifidobacterium has been observed in obese mice supplemented with inulin-type fructans [65]. On the other hand, there is an inverse correlation between the number of Bifidobacterium and the development of fat mass, glucose intolerance, and lipopolysaccharide levels in high-fat diet-induced diabetic mice [66]. Additionally, calorie restriction in mice has been shown to significantly increase the relative abundance of Bifidobacterium [67]. Here, we noted a significant decrease in the relative abundance of Bifidobacterium following LCD-mediated weight loss. The discrepancies in these findings could potentially be explained by differences in dietary content and intervention duration. Consequently, these findings suggest that individuals with obesity should exercise caution when consuming Bifidobacterium-containing prebiotics.

4.5 Implications for individualized therapy of obesity

Obesity is a complex condition influenced by multiple factors, each with its unique dimensions. Hence, one-size-fits-all approaches cannot serve as definitive solutions for effectively addressing obesity. A personalized therapy approach, in line with the current trend in the medical field, is being embraced by basic and clinical researchers as well as patients, particularly in the context of obesity [68]. To successfully implement personalized therapy for obesity, it is crucial to acquire comprehensive information regarding each individual patient. Stratifying obese patients based solely on BMI has its limitations [69]. Factors such as ethnicity, age, sex, and muscle mass can influence the interpretation of body fat levels explained by BMI. Therefore, the introduction of novel biomarkers is essential to better characterize obese patients and facilitate personalized therapy. Fortunately, advancements in sequencing and molecular taxonomic methodologies have made it possible to detect the abundance of specific microbial taxa or even map the entire microbiome fingerprints of individuals. This invaluable information can provide crucial guidance and serve as a theoretical basis for personalized targeted therapy in obesity [70]. In the current study, we observed significant changes in several taxa of the GMB following LCD intervention, which could potentially mediate the weight loss achieved. In the future, specific bacterial taxa may be directly targeted as part of personalized therapy to combat obesity.

In this study, we focused on the effects of short-term LCD intervention on obesity and GMB. Long-term LCDs are also a common strategy for weight loss and blood sugar control [71,72]. Intriguingly, a long-term LCD intervention study reported that microbiota shows resilience (a tendency to return to the initial state) to alterations from the diets despite significant weight loss [73]. However, strict adherence to a long-term LCD may lead to adverse health effects. These can include nutrient deficiencies due to limited intake of important nutrients found in carbohydrate-rich foods like whole grains, fruits, and certain vegetables [74]. Digestive issues like constipation or diarrhea may arise from reduced fiber intake. Muscle loss could occur as a result of severely restricting carbohydrates. Additionally, the long-term sustainability of LCDs may be a concern due to strict dietary restrictions and social limitations, which could impact weight loss or overall health goals [75]. Therefore, it is crucial to seek guidance from healthcare professionals or registered dietitians before making LCD-mediated interventions for obese/overweight individuals.

4.6 Study limitations

Conducting a single-arm study without a control group has some limitations. First, the absence of a control group makes it difficult to determine if the observed changes in the participants’ microbiome are truly attributed to the LCD intervention or if they are due to other factors. Second, without a control group, it is challenging to establish a baseline for comparison, making it hard to quantify the magnitude of the observed changes. Third, the lack of a control group hinders the ability to account for potential confounding variables that might influence the results, such as participants’ lifestyle, diet, or other concurrent interventions. In order to minimize potential confounding factors and identify the microbial taxa that were consistently associated with the LCD intervention, we took the intersection of LEFse and ANOVA analyses when analyzing and further discussing differentially enriched microbiota.

5 Conclusions

In this before–after study, short-term intervention of 4 weeks with LCD resulted in significant reductions in body weight, BMI, body fat, and visceral fat area. Additionally, there was a decrease in total cholesterol levels, indicating the effectiveness of the intervention. The analysis of 16s rRNA gene sequencing data demonstrated a significant increase in the richness of the microbiota following the intervention. By utilizing one-way ANOVA and LEfSe analyses, we identified several microbiota taxa that responded to the LCD intervention. This included three phyla, three classes, four orders, five families, and six genera. Notably, the relative abundance of Firmicutes showed a significant decrease, while that of Bacteroidetes and Actinobacteriota showed a significant increase at the phylum level. At the genus level, Ruminococcus, Agathobacter, Streptococcus, and Bifidobacterium exhibited a significant reduction in relative abundance, whereas Parabacteroides and Bacteroides showed a steady increase. As a whole, our findings demonstrate that LCD can effectively alleviate obesity and induce changes in specific taxa of the GMB. These changes may be involved in LCD-mediated weight loss and provide potential insights for personalized dietary interventions targeting obesity.

While our study demonstrates that LCD can effectively induce weight loss and result in significant changes in the GMB, it is important to mention potential side effects related to LCD, especially in the case of long-term intervention [74]. Thus, we recommend to seek guidance from healthcare professionals or registered dietitians during LCD intervention. Our study also sheds light on the important role that the GMB plays in weight management. However, the specific mechanisms through which the microbiome changes affect body weight and metabolism still require further elucidation. Its impact on host metabolism, energy harvest, appetite regulation, and inflammation remains to be fully clarified. Further, inter-individual variability in diet response strongly suggests the need for future studies considering genetic and environmental factors, and for more targeted, personalized interventions. While we have identified specific microorganisms, such as Firmicutes, Bacteroidetes, and Actinobacteriota as being responsive to LCD, more research should be done to understand their specific roles in weight loss and their potential for utilization in the design of individualized diet plans.

In summary, while our results are encouraging, they represent only a preliminary step toward understanding the complex interactions between diet, GMB, and obesity. Future studies should strive to clarify the underlying mechanisms, examine the long-term effects of these dietary interventions, and explore ways to optimize individual benefits while minimizing potential adverse effects.

# These authors contributed equally to this work.

  1. Funding information: This work was supported by grants from the National Natural Science Foundation of China (No. 82160610, 82000155), and China Health Promotion Foundation (CHPF2018_NALFD).

  2. Author contributions: Mayila Maimaiti and Yasen Maimaitiyiming have full access to all the data produced by the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Mayila Maimaiti, Yasen Maimaitiyiming, and Rashidin Abdugheni. Acquisition, analysis, and interpretation of data: Li Li, Xiaoguo Zhao, Rashidin Abdugheni, Feng Yu, Yunyun Zhao, Ba-Fang Ma, Zhifang Yang, Rongrong Li, and Yue Li. Drafting the manuscript: Li Li, Rashidin Abdugheni, Mayila Maimaiti, and Yasen Maimaitiyiming. Statistical analysis: Mayila Maimaiti. All authors have read and agreed to the publication of the final manuscript version.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Müller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: Advances and challenges. Nat Rev Drug Discov. 2022;21(3):201–23. 10.1038/s41573-021-00337-8.Search in Google Scholar PubMed PubMed Central

[2] Withrow D, Alter DA. The economic burden of obesity worldwide: A systematic review of the direct costs of obesity. Obes Rev. 2011. 2011;12(2):131–41. 10.1111/j.1467-789X.2009.00712.x.Search in Google Scholar PubMed

[3] Lin X, Li H. Obesity: Epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021;12:12706978. 10.3389/fendo.2021.706978.Search in Google Scholar PubMed PubMed Central

[4] World Health Organization. World Obesity Day 2022. Retrieved from: https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesitySearch in Google Scholar

[5] Miethe S, Karsonova A, Karaulov A, Renz H. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685–93. 10.1016/j.jaci.2020.08.011.Search in Google Scholar PubMed

[6] Ng ACT, Delgado V, Borlaug BA, Bax JJ. Diabesity: The combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol. 2021;18(4):291–304. 10.1038/s41569-020-00465-5.Search in Google Scholar PubMed

[7] Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50. 10.1016/j.cytogfr.2018.10.002.Search in Google Scholar PubMed

[8] Syed IUB. Diet, physical activity, and emotional health: What works, what doesn’t, and why we need integrated solutions for total worker health. BMC Public Health. 2020;20(1):152. 10.1186/s12889-020-8288-6.Search in Google Scholar PubMed PubMed Central

[9] Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20–30. 10.1016/S2468-1253(22)00317-X.Search in Google Scholar PubMed

[10] Wilson R, Aminian A. Obesity-associated cancer risk reduction after metabolic surgery: Insights from the SPLENDID study and the path forward. Surg Obes Relat Dis. 2023;19(7):788–93. 10.1016/j.soard.2023.01.027.Search in Google Scholar PubMed

[11] Margolis G, Elbaz-Greener G, Ruskin JN, Roguin A, Amir O, Rozen G. The impact of obesity on sudden cardiac death risk. Curr Cardiol Rep. 2022;24(5):497–504. 10.1007/s11886-022-01671-y.Search in Google Scholar PubMed

[12] Cignarella A, Busetto L, Vettor R. Pharmacotherapy of obesity: An update. Pharmacol Res. 2021;169:105649. 10.1016/j.phrs.2021.105649.Search in Google Scholar PubMed

[13] Akalestou E, Miras AD, Rutter GA, le Roux CW. Mechanisms of weight loss after obesity surgery. Endocr Rev. 2022;43(1):19–34. 10.1210/endrev/bnab022.Search in Google Scholar PubMed PubMed Central

[14] Chao AM, Quigley KM, Wadden TA. Dietary interventions for obesity: Clinical and mechanistic findings. J Clin Invest. 2021;131(1):e140065. 10.1172/JCI140065.Search in Google Scholar PubMed PubMed Central

[15] Larsen AT, Højgaard B, Ibsen R, Kjellberg J. The socio-economic impact of bariatric surgery. Obes Surg. 2018;28(2):338–48. 10.1007/s11695-017-2834-z.Search in Google Scholar PubMed

[16] Dobbie LJ, Tahrani A, Alam U, James J, Wilding J, Cuthbertson DJ. Exercise in obesity-the role of technology in health services: Can this approach work? Curr Obes Rep. 2022;11(3):93–106. 10.1007/s13679-021-00461-x.Search in Google Scholar PubMed PubMed Central

[17] Yannakoulia M, Poulimeneas D, Mamalaki E, Anastasiou CA. Dietary modifications for weight loss and weight loss maintenance. Metabolism. 2019;92:153–62. 10.1016/j.metabol.2019.01.001.Search in Google Scholar PubMed

[18] Chawla S, Tessarolo Silva F, Amaral Medeiros S, Mekary RA, Radenkovic D. The effect of low-fat and low-carbohydrate diets on weight loss and lipid levels: A systematic review and meta-analysis. Nutrients. 2020;12(12):3774. 10.3390/nu12123774.Search in Google Scholar PubMed PubMed Central

[19] Gardner CD, Trepanowski JF, Del Gobbo LC, Hauser ME, Rigdon J, Ioannidis JPA, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: The DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–79. 10.1001/jama.2018.0245.Search in Google Scholar PubMed PubMed Central

[20] Kelly T, Unwin D, Finucane F. Low-carbohydrate diets in the management of obesity and type 2 diabetes: A review from clinicians using the approach in practice. Int J Environ Res Public Health. 2020;17(7):2557. 10.3390/ijerph17072557.Search in Google Scholar PubMed PubMed Central

[21] Cai L, Yin J, Ma X, Mo Y, Li C, Lu W, et al. Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: A randomized clinical trial. Front Med. 2021;15(3):460–71. 10.1007/s11684-021-0861-6.Search in Google Scholar PubMed

[22] Hall KD, Bemis T, Brychta R, Chen KY, Courville A, Crayner EJ, et al. Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity. Cell Metab. 2015;22(3):427–36. 10.1016/j.cmet.2015.07.021.Search in Google Scholar PubMed PubMed Central

[23] Churuangsuk C, Kherouf M, Combet E, Lean M. Low-carbohydrate diets for overweight and obesity: A systematic review of the systematic reviews. Obes Rev. 2018;19(12):1700–18. 10.1111/obr.12744.Search in Google Scholar PubMed

[24] Freire R. Scientific evidence of diets for weight loss: Different macronutrient composition, intermittent fasting, and popular diets. Nutrition. 2020;69:110549. 10.1016/j.nut.2019.07.001.Search in Google Scholar PubMed

[25] Van Hul M, Cani PD. The gut microbiota in obesity and weight management: Microbes as friends or foe. Nat Rev Endocrinol. 2023;19(5):258–71. 10.1038/s41574-022-00794-0.Search in Google Scholar PubMed

[26] David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63. 10.1038/nature12820.Search in Google Scholar PubMed PubMed Central

[27] Gupta A, Osadchiy V, Mayer EA. Brain-gut-microbiome interactions in obesity and food addiction. Nat Rev Gastroenterol Hepatol. 2020;17(11):655–72. 10.1038/s41575-020-0341-5.Search in Google Scholar PubMed PubMed Central

[28] Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214. 10.1126/science.1241214.Search in Google Scholar PubMed PubMed Central

[29] Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23. 10.1073/pnas.0407076101.Search in Google Scholar PubMed PubMed Central

[30] Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: Major fermentation by-products and their impact on host health. Microbiome. 2019;7(1):91. 10.1186/s40168-019-0704-8.Search in Google Scholar PubMed PubMed Central

[31] Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. 10.1038/s41579-020-0433-9.Search in Google Scholar PubMed

[32] Chen F, Hou K, Chen ZS. Gut microbes regulate the feeding center: A new discovery of Gut Brain Axis. Signal Transduct Target Ther. 2022;7(1):284. 10.1038/s41392-022-01117-5.Search in Google Scholar PubMed PubMed Central

[33] Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon AT, et al. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621(7978):389–95. 10.1038/s41586-023-06466-x.Search in Google Scholar PubMed PubMed Central

[34] Pang Y, Zheng Y, Yang N, Zan M, Zhang L, Ding W. Potential novel biomarkers in small intestine for obesity/obesity resistance revealed by multi-omics analysis. Lipids Health Dis. 2022;21(1):98. 10.1186/s12944-022-01711-0.Search in Google Scholar PubMed PubMed Central

[35] Zhu W, Yang D, Chang L, Zhang M, Zhu L, Jiang J. Animal gut microbiome mediates the effects of antibiotic pollution on an artificial freshwater system. J Hazard Mater. 2022;425:127968. 10.1016/j.jhazmat.2021.127968.Search in Google Scholar PubMed

[36] Edgar RC. UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–8. 10.1038/nmeth.2604.Search in Google Scholar PubMed

[37] Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–7. 10.1038/s41587-019-0209-9.Search in Google Scholar PubMed PubMed Central

[38] Xu W, Chen T, Pei Y, Guo H, Li Z, Yang Y, et al. Characterization of shallow whole-metagenome shotgun sequencing as a high-accuracy and low-cost method by complicated mock microbiomes. Front Microbiol. 2021;12:678319. 10.3389/fmicb.2021.678319.Search in Google Scholar PubMed PubMed Central

[39] Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. 10.1038/s41392-022-00974-4.Search in Google Scholar PubMed PubMed Central

[40] Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance. Ann N Y Acad Sci. 2020;1461(1):37–52. 10.1111/nyas.14107.Search in Google Scholar PubMed

[41] Yang X, Xie L, Li Y, Wei C. More than 9,000,000 unique genes in human gut bacterial community: Estimating gene numbers inside a human body. PLoS One. 2009;4(6):e6074. 10.1371/journal.pone.0006074.Search in Google Scholar PubMed PubMed Central

[42] Zhu B, Wang X, Li L. Human gut microbiome: The second genome of human body. Protein Cell. 2010;1(8):718–25. 10.1007/s13238-010-0093-z.Search in Google Scholar PubMed PubMed Central

[43] Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, et al. Gut microbiota markers associated with obesity and overweight in Italian adults. Sci Rep. 2021;11(1):5532. 10.1038/s41598-021-84928-w.Search in Google Scholar PubMed PubMed Central

[44] Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. 10.1038/4441022a.Search in Google Scholar PubMed

[45] Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring). 2013;21(12):E607–15. 10.1002/oby.20466.Search in Google Scholar PubMed

[46] Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94(1):58–65. 10.3945/ajcn.110.010132.Search in Google Scholar PubMed PubMed Central

[47] Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27(2):201–14. 10.1177/0884533611436116.Search in Google Scholar PubMed PubMed Central

[48] Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One. 2010;5(11):e15046. 10.1371/journal.pone.0015046.Search in Google Scholar PubMed PubMed Central

[49] Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190–5. 10.1038/oby.2009.167.Search in Google Scholar PubMed

[50] Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond). 2008;32(11):1720–4. 10.1038/ijo.2008.155.Search in Google Scholar PubMed

[51] Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, et al. The Firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):1474. 10.3390/nu12051474.Search in Google Scholar PubMed PubMed Central

[52] Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother. 2022;147:112678. 10.1016/j.biopha.2022.112678.Search in Google Scholar PubMed

[53] Pavlostathis SG, Miller TL, Wolin MJ. Cellulose fermentation by continuous cultures of Ruminococcus albus and Methanobrevibacter smithii. Appl Microbiol Biotechnol. 1990;33:109–16. 10.1007/BF00170581.Search in Google Scholar

[54] Lin H, An Y, Tang H, Wang Y. Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model. J Agric Food Chem. 2019;67(13):3624–32. 10.1021/acs.jafc.9b00249.Search in Google Scholar PubMed

[55] Jinato T, Chayanupatkul M, Dissayabutra T, Chutaputti A, Tangkijvanich P, Chuaypen N. Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: A randomized double-blinded, placebo-controlled study. Nutrients. 2022;14(14):2921. 10.3390/nu14142921.Search in Google Scholar PubMed PubMed Central

[56] Ott B, Skurk T, Hastreiter L, Lagkouvardos I, Fischer S, Büttner J, et al. Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women. Sci Rep. 2017;7(1):11955. 10.1038/s41598-017-12109-9.Search in Google Scholar PubMed PubMed Central

[57] Langley G, Hao Y, Pondo T, Miller L, Petit S, Thomas A, et al. The impact of obesity and diabetes on the risk of disease and death due to invasive group a streptococcus infections in adults. Clin Infect Dis. 2016;62(7):845–52. 10.1093/cid/civ1032.Search in Google Scholar PubMed

[58] Jain A, Li XH, Chen WN. Similarities and differences in gut microbiome composition correlate with dietary patterns of Indian and Chinese adults. AMB Express. 2018;8(1):104. 10.1186/s13568-018-0632-1.Search in Google Scholar PubMed PubMed Central

[59] Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26(1):222–35.e5. 10.1016/j.celrep.2018.12.028.Search in Google Scholar PubMed

[60] Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, et al. Gut commensalParabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 2019;68(2):248–62. 10.1136/gutjnl-2017-315458.Search in Google Scholar PubMed

[61] Qiao S, Liu C, Sun L, Wang T, Dai H, Wang K, et al. Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism. Nat Metab. 2022;4(10):1271–86. 10.1038/s42255-022-00649-y.Search in Google Scholar PubMed

[62] Yang JY, Lee YS, Kim Y, Lee SH, Ryu S, Fukuda S, et al. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol. 2017;10(1):104–16. 10.1038/mi.2016.42.Search in Google Scholar PubMed

[63] Yoshida N, Yamashita T, Osone T, Hosooka T, Shinohara M, Kitahama S, et al. Bacteroides spp. promotes branched-chain amino acid catabolism in brown fat and inhibits obesity. iScience. 2021;24(11):103342. 10.1016/j.isci.2021.103342.Search in Google Scholar PubMed PubMed Central

[64] Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7(11):639–46. 10.1038/nrendo.2011.126.Search in Google Scholar PubMed

[65] Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van Holle A, Muccioli GG, et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem. 2011;22(8):712–22. 10.1016/j.jnutbio.2010.05.009.Search in Google Scholar PubMed

[66] Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374–83. 10.1007/s00125-007-0791-0.Search in Google Scholar PubMed

[67] Wang S, Huang M, You X, Zhao J, Chen L, Wang L, et al. Gut microbiota mediates the anti-obesity effect of calorie restriction in mice. Sci Rep. 2018;8(1):13037. 10.1038/s41598-018-31353-1.Search in Google Scholar PubMed PubMed Central

[68] El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol. 2013;9(7):402–13. 10.1038/nrendo.2013.57.Search in Google Scholar PubMed

[69] Daniels SR. The use of BMI in the clinical setting. Pediatrics. 2009;124 (Suppl 1):S35–41. 10.1542/peds.2008-3586F.Search in Google Scholar PubMed

[70] Tomasello G, Mazzola M, Jurjus A, Cappello F, Carini F, Damiani P, et al. The fingerprint of the human gastrointestinal tract microbiota: A hypothesis of molecular mapping. J Biol Regul Homeost Agents. 2017;31(1):245–9.Search in Google Scholar

[71] Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials. Br J Nutr. 2013;110(7):1178–87. 10.1017/S0007114513000548.Search in Google Scholar PubMed

[72] Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: A randomized trial. Diabetes Care. 2014;37(11):2909–18. 10.2337/dc14-0845.Search in Google Scholar PubMed

[73] Fragiadakis GK, Wastyk HC, Robinson JL, Sonnenburg ED, Sonnenburg JL, Gardner CD. Long-term dietary intervention reveals resilience of the gut microbiota despite changes in diet and weight. Am J Clin Nutr. 2020;111(6):1127–36. 10.1093/ajcn/nqaa046.Search in Google Scholar PubMed PubMed Central

[74] Barber TM, Hanson P, Kabisch S, Pfeiffer AFH, Weickert MO. The low-carbohydrate diet: Short-term metabolic efficacy versus longer-term limitations. Nutrients. 2021;13(4):1187. 10.3390/nu13041187.Search in Google Scholar PubMed PubMed Central

[75] Brinkworth GD, Wycherley TP, Noakes M, Buckley JD, Clifton PM. Long-term effects of a very-low-carbohydrate weight-loss diet and an isocaloric low-fat diet on bone health in obese adults. Nutrition. 2016;32(9):1033–6. 10.1016/j.nut.2016.03.003.Search in Google Scholar PubMed

Received: 2023-08-28
Revised: 2023-10-20
Accepted: 2023-11-14
Published Online: 2024-01-27

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
https://doi.org/10.1515/biol-2022-0803
Keywords for this article
low-carbohydrate diet; gut microbiota; obesity; weight loss; 16s rRNA sequencing
Creative Commons
BY 4.0

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0803/html
Scroll to top button